Cargando…
Natamycin solid lipid nanoparticles – sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization
BACKGROUND: Fungal keratitis (FK) is a serious pathogenic condition usually associated with significant ocular morbidity. Natamycin (NAT) is the first-line and only medication approved by the Food and Drug Administration for the treatment of FK. However, NAT suffers from poor corneal penetration, wh...
Autores principales: | Khames, Ahmed, Khaleel, Mohammad A, El-Badawy, Mohamed F, El-Nezhawy, Ahmed O H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6459158/ https://www.ncbi.nlm.nih.gov/pubmed/31040672 http://dx.doi.org/10.2147/IJN.S190502 |
Ejemplares similares
-
Natamycin versus natamycin combined with voriconazole in the treatment of fungal keratitis
por: Cai, Jingjing, et al.
Publicado: (2023) -
Evaluation of cyclodextrins for enhancing corneal penetration of natamycin eye drops
por: Badhani, Anjali, et al.
Publicado: (2012) -
Natamycin Ocular Delivery: Challenges and Advancements in Ocular Therapeutics
por: Mascarenhas, Mabel, et al.
Publicado: (2023) -
Determination of surgical outcomes with a novel formulation of intrastromal natamycin in recalcitrant fungal keratitis: A pilot study
por: Saluja, Gunjan, et al.
Publicado: (2021) -
Nanocubosomal based in situ gel loaded with natamycin for ocular fungal diseases: development, optimization, in-vitro, and in-vivo assessment
por: Hosny, Khaled M., et al.
Publicado: (2021)